What’s Missing from ICER’s Assessment of Abuse-Deterrent Opioids
June 2, 2017
Abuse-deterrent formulations (ADF) of opioids resist crushing or dissolving for misuse, helping to curb widespread opioid abuse.
But a recent report from the Institute for Clinical and Economic Review underestimates ADFs’ value by ignoring several key benefits.
Tags: Cost Value, PainCategorized in: Analysis